首页> 外文会议>International Symposium of Biomedical Engineering >The Effect of Acalypha indica Linn. Extract on Insulin Resistance in Sprague-Dawley Rats after Induction of High Cholesterol-High Fructose Diet
【24h】

The Effect of Acalypha indica Linn. Extract on Insulin Resistance in Sprague-Dawley Rats after Induction of High Cholesterol-High Fructose Diet

机译:Acalypha indaLINA的影响。高胆固醇高果糖饮食诱导后Sprague-Dawley大鼠胰岛素抗性提取物

获取原文

摘要

Type 2 diabetes mellitus is a metabolic disorder that is characterized by hyperglycemia, insulin resistance, inadequate insulin secretion, and excessive glucagon secretion. Metformin is the first-line medication prescribed for type 2 diabetes mellitus. Prolonged use of metformin can cause mild and serious side effects. One of the alternative herbal remedies used to treat Type 2 diabetes mellitus is Acalypha indica Linn (AI). The objective of this research is to investigate the effect of ethanol extract AI to insulin resistance. Thirty male Sprague-Dawley rats are divided into six group, four groups (negative control, metformin 100 mg/kgBW/day, AI extract 250 mg/kgBW/day, combination metformin and AI extract) are induced with high fructose and high cholesterol diet; while two other groups (normal and normal treated with AI extract) are given normal diet. After four weeks of treatment, rats were terminated and laboratory test was performed to see plasma insulin level using enzyme-linked immunosorbent assay. We found that AI extract significantly reduced plasma insulin level (p=0,018), similar to metformin (p=0,009), compare with negative control. In addition, we also calculate insulin resistance index using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) based on plasma insulin level and blood glucose level. The combination of metformin and AI extract significantly decreased the insulin resistance index compared with the negative control (p=0,034). Therefore, AI extract can be used as a complementary to metformin therapy in type 2 diabetes mellitus and also as a prevention therapy of insulin resistance on normal individual.
机译:2型糖尿病是一种代谢紊乱,其特征在于高血糖,胰岛素抵抗,胰岛素分泌和过量胰高血糖素分泌。二甲双胍是针对2型糖尿病规定的一线药物。长时间使用二甲双胍会导致轻度和严重的副作用。用于治疗2型糖尿病的替代草药补救措施是Agalypha Indica Linn(AI)。本研究的目的是探讨乙醇提取物AI对胰岛素抵抗的影响。三十只雄性Sprague-Dawley大鼠分为六组,四组(阴性对照,二甲双胍100mg / kgbw /天,AI提取物250mg / kgbw /天,组合二甲双胍和ai提取物)伴有高果糖和高胆固醇饮食;虽然另外两组(用AI提取物治疗正常和正常治疗)是正常的饮食。治疗四周后,终止大鼠,并使用酶联免疫吸附测定进行实验室测试以见血浆胰岛素水平。我们发现AI提取物显着减少了血浆胰岛素水平(p = 0,018),类似于二甲双胍(p = 0,009),与负控制进行比较。此外,我们还使用基于血浆胰岛素水平和血糖水平的胰岛素抵抗(HOMA-IR)的稳态模型评估来计算胰岛素抵抗指数。与阴性对照相比,二甲双胍和AI提取物的组合显着降低了胰岛素阻力指数(P = 0.034)。因此,AI提取物可以用作2型糖尿病患者的二甲双胍治疗互补,也可以作为正常个体对胰岛素抵抗的预防治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号